Cassava Sciences has the most promising drug for Alzheimer's in History, Simufilam and its being Naked shorted by Hedge Fund managers and Brokers. Hedge Funds and Short and Distort Sellers are sacrificing your Family Members that have Alzheimer's.
Wake Up People.
https://t.co/exurorAMcC
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret
Mr. He/Him Martin,
We did more DD vs you will ever do. And even you consider yourself “smart autistic” dude, you really never made money by running a company and by investing, just with CP frauds (hence you ended up in jail).
Some of us, made companies and money on stock, and your short thesis should be applied when $sava was in $140 not right now genius. Right now losing “everything” like what? 30 to cash value? You are little too late too short bro.
Your post brings 0.00 new value, and you been saying same stuff as shorts said for 3 years. Nothing new.
Bring new stuff up and we can talk, again, you are use to bullying dudes that have lower resume vs you, but for us, that have few million in sava and are willing to lose your are really irrelevant (although you are entertaining).
$sava simufilam patient with AD for ~8 years entered study at a 16 MMSE - Performs Sax Solo!!!
Just got an absolutely incredible update on patient number 1. He recently put on a Jazz performance with his band. He is playing saxophone. One patient that started the trial as a 17-18 was diagnosed with AD in 2016. A 16 MMSE was probably diagnosed with AD around 2016 as well... so 8 years with the disease and he can do a VERY GOOD SAX SOLO? WOW!!!
Patient 1
Refocus ~Nov 2022 - May 2024 : 16 MMSE to 20 MMSE
They said they will be sending evidence of their pill as well.
$sava simufilam patient with AD for ~8 years entered study at a 16 MMSE - Performs Sax Solo!!!
Just got an absolutely incredible update on patient number 1. He recently put on a Jazz performance with his band. He is playing saxophone. One patient that started the trial as a 17-18 was diagnosed with AD in 2016. A 16 MMSE was probably diagnosed with AD around 2016 as well... so 8 years with the disease and he can do a VERY GOOD SAX SOLO? WOW!!!
Patient 1
Refocus ~Nov 2022 - May 2024 : 16 MMSE to 20 MMSE
They said they will be sending evidence of their pill as well.
Shorts looking at $DRUG today & wondering what will happen to their short positions in $SAVA if it posts a 1-day 1,200+% rise. 🤣
Trembling yet, shorts? 😂
$SAVA #Bullish IMO
@TEXTILE_FIBER https://t.co/n2NPEKXeG5
@JamesOKeefeIII@WarrenDavidson
Jim Cramer is blatantly describing how he uses lies about insider information to manipulate market prices for stocks he's short on destroying the share price for Retail investors.
This man should be in prison
https://t.co/gk3KEHPs6v
The TGA delegate decided not to register LEQEMBI on the basis that the demonstrated efficacy did not outweigh the safety risks associated with the use of this medicine. Cassava Sciences has the most promising drug for Alzheimer's in History, Simufilam
Patient 7 Update - Confirmed MMSE stable at 14 after 10 months on Treatment with simufilam
14 MMSE still stable after 10 months on treatment in REFOCUS OLE - Historical placebo would decline 2.5 MMSE or 5 ADAS-cog11 over similar timeframe
She was in $sava simufilam Phase 3 Refocus -
Diagnosed 2016 with Alzheimer's
Blinded Refocus 18 Months
July 2022 - Jan 2024 :
17-18 MMSE at start declined to 14
Refocus 12 Month OLE Jan 2024 - July 2024:
On the medicine for 6 months maintained at 14 after dropping 1.3 MMSE points every six months while blinded . Husband believes she was on placebo, but stabilized. He believes there is a treatment effect on the open label.
UPDATE Oct 8th 2024 "we returned from the Clinic today and she is still stable with an MMSE of 14."
Thanks for Fighting with me Against the Evil Trying to Slow down Cures to Disease
As I write this, I get tears in my eyes because your support of the efforts at Cure Guardian makes me emotional. I feel like I have poured all I have into fighting against those trying to stop a cure to Alzheimer's. Primarily I have fought this fight as a keyboard warrior The support from you is what keeps me going...
A husband that has a wife in the open label trial on $sava simufilam emailed me after the latest @adamfeuerstein tabloid article.
He said "I couldn’t resist contacting you after seeing Feuerstein’s once again call for the trials to be halted given his “concern” for Alzheimer’s patients. It speaks volumes that he is still pleading for the trials to be shut down just weeks/month before a read out of the topline results from one of the phase 3s. Of course, if he were sure the drug didn’t work, he wouldn’t need to call for the clinicals to be halted, he would be proven correct very shortly."
This man fought with me to persuade Cassava to take the massive business risk to fund ~1900 to continue on a very expensive open label trial. She has stabilized her disease symptoms after likely being on placebo in REFOCUS. He is fighting a 3 front war... He fights for his wife's life against the disease. He is fighting to keep access to a drug that has slowed down his wife's disease. Now he has to fight the evil in the world spreading doubt about the drug for profit. The evil he fights is why I started Cure Guardian.
The short selling hedge funds and funders of the efforts to slow drug development are running loose now with no accountability. These sick people use investigative bodies (FBI, SEC, NIH, journals, ORI, and FDA) that we all fund to investigate and choke resources at our innovative and resource strapped biotech's. These investigations massively scale their effort. ORI only finds research misconduct in 3.5% of the allegations waged against research funding at NIH. The media also scales their effort for free and makes advertising and subscription revenue from the accusations. Once the accusations are public... the goal is met and the damage is done.
The world has been on a 118 year journey fighting against #AlzheimersDisease since 1906 when it was discovered by Dr. Alois Alzheimer. The disease is challenging enough, but why does our world make Dr. Lindsay Burns and Dr. Hoau-Yan Wang to also have to fight against the trolls in the media, fraud hunting community, and short sellers?
Anyway... thank you thank you thank you for your support. For those that want to join the effort, the best way to do that now is to donate.
https://t.co/H2cTs6aPb6
To learn more about the 501c3 non profit visit: https://t.co/iZcFlGs0J1
@teddyrosenbluth DM me if you want to learn more about the patients that Roger Nicoll and George Perry are not protecting as they claim. I could also explain the EXTREME conflict of interests they have and likely did not disclose to you.
We interviewed the family today. As you can see we are executing the documentation of a family’s experience with $sava simufilam very thoroughly. He’s been on the treatment nearly 4 years. I look forward to sharing it with everyone. They have a wonderful large family.
We interviewed the family today. As you can see we are executing the documentation of a family’s experience with $sava simufilam very thoroughly. He’s been on the treatment nearly 4 years. I look forward to sharing it with everyone. They have a wonderful large family.
Thanks for Fighting with me Against the Evil Trying to Slow down Cures to Disease
As I write this, I get tears in my eyes because your support of the efforts at Cure Guardian makes me emotional. I feel like I have poured all I have into fighting against those trying to stop a cure to Alzheimer's. Primarily I have fought this fight as a keyboard warrior The support from you is what keeps me going...
A husband that has a wife in the open label trial on $sava simufilam emailed me after the latest @adamfeuerstein tabloid article.
He said "I couldn’t resist contacting you after seeing Feuerstein’s once again call for the trials to be halted given his “concern” for Alzheimer’s patients. It speaks volumes that he is still pleading for the trials to be shut down just weeks/month before a read out of the topline results from one of the phase 3s. Of course, if he were sure the drug didn’t work, he wouldn’t need to call for the clinicals to be halted, he would be proven correct very shortly."
This man fought with me to persuade Cassava to take the massive business risk to fund ~1900 to continue on a very expensive open label trial. She has stabilized her disease symptoms after likely being on placebo in REFOCUS. He is fighting a 3 front war... He fights for his wife's life against the disease. He is fighting to keep access to a drug that has slowed down his wife's disease. Now he has to fight the evil in the world spreading doubt about the drug for profit. The evil he fights is why I started Cure Guardian.
The short selling hedge funds and funders of the efforts to slow drug development are running loose now with no accountability. These sick people use investigative bodies (FBI, SEC, NIH, journals, ORI, and FDA) that we all fund to investigate and choke resources at our innovative and resource strapped biotech's. These investigations massively scale their effort. ORI only finds research misconduct in 3.5% of the allegations waged against research funding at NIH. The media also scales their effort for free and makes advertising and subscription revenue from the accusations. Once the accusations are public... the goal is met and the damage is done.
The world has been on a 118 year journey fighting against #AlzheimersDisease since 1906 when it was discovered by Dr. Alois Alzheimer. The disease is challenging enough, but why does our world make Dr. Lindsay Burns and Dr. Hoau-Yan Wang to also have to fight against the trolls in the media, fraud hunting community, and short sellers?
Anyway... thank you thank you thank you for your support. For those that want to join the effort, the best way to do that now is to donate.
https://t.co/H2cTs6aPb6
To learn more about the 501c3 non profit visit: https://t.co/iZcFlGs0J1
@teddyrosenbluth DM me if you want to learn more about the patients that Roger Nicoll and George Perry are not protecting as they claim. I could also explain the EXTREME conflict of interests they have and likely did not disclose to you.
🚨 🔔 Has anyone heard caught $LLY CEO DAVE RICKS TALK about MISFOLDED PROTEIN…. Guess I heard about this somewhere….. $SAVA
#Alzheimer
Listen closely….
#SIMUFILAM#FLNA is ALL ABOUT MISFOLDED PROTEIN
RETHINK phase 3 reads out by Cassava Sciences, $sava, end of November or December of 2024. We know the drug is safe, so it comes down to effectiveness that could be demonstrated in the RETHINK readout. Answering a question on a tweet on what I think the stock price will do this year...
Here are my price estimates depending on data:
1. RETHINK does not show stat sig improvement in mild or moderate - Price will likely goto $10 or lower and wait for REFOCUS, but not good and shorts win. 5% chance this happens
2. RETHINK shows stat sig for Mild and not for moderate and not for total. Lets say Mild slows decline by 30% or similar to $lly and $Biib MAB treatments. Stock will goto $50+ after readout then drift up toward a $10B market cap or $250. 5% chance this happens
3. RETHINK beats the MABS and slows mild patients cognition 50% better than placebo. Moderate not significant and total not significant. The stock should goto $80+ then drift to $350 because it will be a blockbuster. 5% chance this happens.
4. RETHINK reads out MILD as improvement in cognition, so a 100% or greater than placebo. Moderate not significant, but overall is significant. Stock should goto $200 instantly, then drift up to $500+. Proves that if you take simufilam early you will not get AD symptoms. 20% chance this happens
5. RESULT I EXPECT - RETHINK reads out as Mild improvement AND Moderate better than placebo. So Mild's improve over 100% to placebo and moderate improve 30-50% decline than placebo. Stock will instantly goto $300 plus and drift toward $2000. Mega blockbuster drug, but slower uptake. 35% chance this happens
6. RETHINK on average improves the entire treatment group cognition at 1 year, so improvement over placebo > 100%. Stock will instantly goto 500 and rise toward $3000+. Mega blockbuster drug that solves the AD crisis and world wide medical and government will get behind getting the drug out as fast as possible. 30% chance this happens.